Non-enzymatic proteins from snake venoms: A gold mine of pharmacological tools and drug leads

Toxicon

Volumn 62, Issue , 2013, Pages 56-74

  McCleary, Ryan J R ^a   Kini, R Manjunatha ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

ACE inhibitor; Botrocetin; Dendrotoxin; Nerve growth factor; Snake toxin; Snake venom

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BOTROCETIN; BRADYKININ POTENTIATING FACTOR; CAPTOPRIL; COBROTOXIN; CONVULXIN; CYSTEINE RICH SECRETORY PROTEIN; DENDROTOXIN; ENALAPRIL; NERVE GROWTH FACTOR; PLACENTAL GROWTH FACTOR; SARAFOTOXIN; SNAKE VENOM; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VENOM IX BINDING FACTOR; VENOM X BINDING FACTOR;

ANTICOAGULATION; BLOOD PRESSURE REGULATION; COMPLEMENT ACTIVATION; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; EXCITEMENT; NEUROTOXICITY; NONHUMAN; PHARMACEUTICAL CARE; PHARMACOLOGICAL SCIENCE; PHARMACOPHORE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION;

ANTICOAGULANTS; CARDIOTOXINS; COMPLEMENT PATHWAY, ALTERNATIVE; CROTALID VENOMS; DRUG DESIGN; ELAPID VENOMS; ENDOTHELINS; LECTINS, C-TYPE; NATRIURETIC PEPTIDES; NERVE GROWTH FACTOR; NEUROMUSCULAR JUNCTION; OLIGOPEPTIDES; SNAKE VENOMS; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872499128     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.09.008     Document Type: Review

References (158)

1. Alirol E., Sharma S.K., Bawaskar H.S., Kuch U., Chappuis F. Snake bite in South Asia: a review. PLOS Neglected Trop. Dis. 2010, 4:e603.
2. Alper C.A., Balavitch D. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science 1976, 191:1275-1276.
3. Alper C.A., Goodkofsky I., Lepow I.H. The relationships of glycine-rich β-glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of human serum. J. Exp. Med. 1973, 137:424-437.
4. Anderson A.J., Harvey A.L. Effects of the potassium channel blocking dendrotoxins on acetylcholine release and motor nerve terminal activity. Br. J. Pharmacol. 1988, 93:215-221.
5. Atoda H., Morita T. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization. J. Biochem. (Tokyo) 1989, 106:808-813.
6. Atoda H., Hyuga M., Morita T. The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Homology with asialoglycoprotein receptors, proteoglycan core protein, tetranectin, and lymphocyte Fce{open} receptor for immunoglobulin E. J. Biol. Chem. 1991, 266:14903-14911.
7. Bakhle Y.S. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 1968, 220:919-921.
8. Bakhle Y.S., Reynard A.M., Vane J.R. Metabolism of the angiotensins in isolated perfused tissues. Nature 1969, 222:956-959.
9. Barrett J.C., Harvey A.L. Effects of the venom of the green mamba, Dendroaspis angusticeps on skeletal muscle and neuromuscular transmission. Br. J. Pharmacol. 1979, 67:199-205.
10. Bdolah A. Sarafotoxins, the snake venom homologs of the endothelins. Handbook of Venom and Toxins of Reptiles 2010, 303-315. CRC Press, Taylor & Francis Group, Roca Raton, London and New York. S.P. Mackessy (Ed.).
11. Benoit E., Dubois J.M. Toxin I from the snake Dendroaspis polylepis polylepis: a highly specific blocker of one type of potassium channel in myelinated nerve fiber. Brain Res. 1986, 377:374-377.
12. Biel M., Michalakis S. Function and dysfunction of CNG channels: insights from channelopathies and mouse models. Mol. Neurobiol. 2007, 35:266-277.
13. Brazil V. Contribuição ao estudo de veneno ophidico. II. veneno de algumas espécies brazileiras. Rev. Méd. São Paulo 1901, 4:296-300.
14. Brown R.L., Haley T.L., West K.A., Crabb J.W. Pseudechetoxin: a peptide blocker of cyclic nucleotide-gated ion channels. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:754-759.
15. Brown R.L., Lynch L.L., Haley T.L., Arsanjani R. Pseudechetoxin binds to the pore turret of cyclic nucleotide-gated ion channels. J. Gen. Physiol. 2003, 122:749-760.
16. Brown R.L., Strassmaier T., Brady J.D., Karpen J.W. The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness. Curr. Pharm. Des. 2006, 12:3597-3613.
17. Byers L.D., Wolfenden R. A potent reversible inhibitor of carboxypeptidase A. J. Biol. Chem. 1972, 247:606-608.
18. Calvete J.J. The continuing saga of snake venom disintegrins. Toxicon 2013, 62:40-49.
19. Clemetson K.J. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to receptors. Toxicon 2010, 56:1236-1246.
20. Clemetson K.J. Snaclecs (snake C-type lectins) that inhibit platelet receptors. Toxins and Hemostasis from Bench to Bedside 2010, 359-368. Springer, Dordrecht. R.M. Kini, K.J. Clemetson, F.S. Markland, M.A. McLane, T. Morita (Eds.).
21. Clemetson K.J., Lu Q., Clemetson J.M. Snake C-type lectin-like proteins and platelet receptors. Pathophysiol. Haemost. Thromb. 2005, 34:150-155.
22. Clemetson K.J., Morita T., Kini R.M. Scientific and standardization committee communications: classification and nomenclature of snake venom C-type lectins and related proteins. J. Thromb. Haemost. 2009, 7:360.
23. Cohen S., Levi-Montalcini R. A nerve growth-stimulating factor isolated from snake venom. Proc. Natl. Acad. Sci. U. S. A. 1956, 42:571-574.
24. Cominetti M.R., Terruggi C.H., Ramos O.H., Fox J.W., Mariano-Oliveira A., De Freitas M.S., Figueiredo C.C., Morandi V., Selistre-de-Araujo H.S. Alternagin-C, a disintegrin-like protein, induces vascular endothelial cell growth factor (VEGF) expression and endothelial cell proliferation in vitro. J. Biol. Chem. 2004, 279:18247-18255.
25. Cushman D.W., Cheung H.S., Sabo E.F., Ondetti M.A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 1977, 16:5484-5491.
26. Dickey D.M., Potter L.R. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. J. Mol. Cell. Cardio. 2011, 51:67-71.
27. Dickey D.M., Burnett J.C., Potter L.R. Novel bifunctional natriuretic peptides as potential therapeutics. J. Biol. Chem. 2008, 283:35003-35009.
28. Du X.-Y., Clemetson K.J. Reptile C-type lectins. Handbook of Venoms and Toxins of Reptiles 2009, 359-376. CRC Press, Boca Raton. S.P. Mackessy (Ed.).
29. Ducancel F. Endothelin-like peptides. Cell. Mol. Life Sci. 2005, 62:2828-2839.
30. Erdös E.G. Hypotensive peptides: bradykinin, kallidin, and eledoisin. Adv. Pharmacol. 1966, 4:1-90.
31. Ferreira S.H. A Bradykinin-potentiation factor (BPF) present in the venom of Bothrops jararaca. Br. J. Pharmacol. 1965, 24:163-169.
32. Ferreira S.H. Bradykinin-potentiating factor. Hypotensive Peptides 1966, 356-367. Springer Verlag, New York. E.G. Erdös (Ed.).
33. Ferreira S.H., Vane J.R. The detection and estimation of bradykinin in the circulating blood. Br. J. Pharmacol. Chemother. 1967, 29:367-377.
34. Ferreira S.H., Vane J.R. The detection and estimation of bradykinin in the circulation and vascular beds of the cat. Br. J. Pharmacol. Chemother. 1967, 30:417-424.
35. Ferreira S.H., Bartelt D.C., Greene L.J. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 1970, 9:2583-2593.
36. Ferreira S.H., Greene L.H., Alabaster V.A., Bakhle Y.S., Vane J.R. Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme. Nature 1970, 225:379-380.
37. Flexner S., Noguchi H. Snake venom in relation to haemolysis, bacteriolysis, and toxicity. J. Exp. Med. 1903, 6:277-301.
38. Fritzinger D.C., Bredehorst R., Vogel C.-W. Molecular cloning and derived primary structure of cobra venom factor. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:12775-12779.
39. Fritzinger D.C., Hew B.E., Thorne M., Pangburn M.K., Janssen B.J.C., Gros P., Vogel C.-W. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion. Dev. Comp. Immunol. 2009, 33:105-116.
40. 2 homologue binds to vascular endothelial growth factor recepter-2 via a C-terminal loop region. Biochem. J. 2008, 411:515-522.
41. Fukuda K., Doggett T., Laurenzi I.J., Liddington R.C., Diacovo T.G. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation. Nat. Struct. Mol. Biol. 2005, 12:152-159.
42. Gainer J.V., Morrow J.D., Loveland A., King D.J., Brown N.J. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N. Engl. J. Med. 1998, 339:1285-1292.
43. Gavras H., Brunner H.R., Laragh J.H., Sealey J.E., Gavras I., Vukovich R.A. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med. 1974, 291:817-821.
44. Götze O., Müller-Eberhard H.J. The C3-activator system: an alternative pathway of complement activation. J. Exp. Med. 1971, 134:90s-108s.
45. Greene L.J., Stewart J.M., Ferreira S.H. Bradykinin-potentiating peptides from the venom of Bothrophs Jararaca. Bradykinin and Related Kinins: Cardiovascular, Biochemical and Neural Actions 1970, 81-87. Plenum Press, New York. M. Sicuteri, M. Rocha e Silva, N. Back (Eds.).
46. Halliwell J.V., Othman I.B., Pelchen-Matthews A., Dolly J.O. Central action of dendrotoxin: selective reduction of a transient K conductance in hippocampus and binding to localized acceptors. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:493-497.
47. Harvey A.L., Karlsson E. Dendrotoxin from the venom of the green mamba, Dendroaspis angusticeps. A neurotoxin that enhances acetylcholine release at neuromuscular junction. Naunyn Schmiedeberg's Arch. Pharmacol. 1980, 312:1-6.
48. Harvey A.L., Karlsson E. Protease inhibitor homologues from mamba venoms: facilitation of acetylcholine release and interactions with prejunctional blocking toxins. Br. J. Pharmacol. 1982, 77:153-161.
49. Harvey A.L., Robertson B. Dendrotoxins: structure-activity relationships and effects on potassium ion channels. Curr. Med. Chem. 2004, 11:3065-3072.
50. Hegde R.P., Rajagopalan N., Doley R., Kini R.M. Snake venom three-finger toxins. Handbook of Venoms and Toxins of Reptiles 2009, 287-302. CRC Press, Boca Raton. S.P. Mackessy (Ed.).
51. Horii D., Okuda D., Morita T., Mizuno H. Crystal structure of EMS16 in complex with the integrin α2-I domain. J. Mol. Biol. 2004, 341:519-527.
52. Horii K., Brooks M.T., Herr A.B. Convulxin forms a dimer in solution and can bind eight copies of glycoprotein VI: implications for platelet activation. Biochemistry 2009, 48:2907-2914.
53. Hunsicker L.G., Ruddy S., Austen K.F. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J. Immunol. 1973, 110:128-137.
54. 1. J. Biol. Chem. 1997, 272:27035-27041.
55. Janssen B.J.C., Gomes L., Koning R.I., Svergun D.I., Koster A.J., Fritzinger D.C., Vogel C.-W., Gros P. Insights into complement convertase formation based on the structure of factor B-cobra venom factor complex. EMBO J. 2009, 28:2469-2478.
56. Joubert F.J., Taljaard N. Snake venoms. The amino acid sequences of two proteinase inhibitor homologues from Dendroaspis angusticeps venom. Hoppe-Seyler's Z. Physiol. Chem. 1980, 361:661-674.
57. Kaser A., Winklmayr M., Lepperdinger G., Kreil G. The AVIT protein family. Secreted cysteine-rich vertebrate proteins with diverse functions. EMBO Rep. 2003, 4:469-473.
58. Kaupp U.B., Seifert R. Cyclic nucleotide-gated ion channels. Physiol. Rev. 2002, 82:769-824.
59. Kini R.M. Molecular moulds with multiple missions: functional sites in three-finger toxins. Clin. Exp. Pharmacol. Physiol. 2002, 29:815-822.
60. Kini R.M., Doley R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon 2010, 56:855-867.
61. Kini R.M., Rajaseger G., Chung M.M. Helveprins, a new family of proteins from snake venoms. Toxicon 2001, 39:139.
62. Kloog Y., Ambar I., Sokolovsky M., Kochva E., Wollberg Z., Bdolah A. Sarafotoxin, a novel vasoconstrictor peptide: phosphoinositide hydrolysis in rat heart and brain. Science 1988, 242:268-270.
63. Kloog Y., Bousso-Mittler D., Bdolah A., Sokolovsky M. Three apparent receptor subtypes for the endothelin/sarafotoxin family. FEBS Lett. 1989, 253:199-202.
64. Koch S., Tugues S., Li X., Gualandi L., Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011, 437:169-183.
65. Kochva E., Viljoen C.C., Botes D.P. A new type of toxin in the venom of snakes of the genus Atractaspis (Atractaspidinae). Toxicon 1982, 20:581-592.
66. Kock M.A., Hew B.E., Bammert H., Fritzinger D.C., Vogel C.-W. Structure and function of recombinant cobra venom factor. J. Biol. Chem. 2004, 279:30836-30843.
67. Komori Y., Sugihara H. Purification and physiological study of a hypotensive factor from the venom of Vipera aspis aspis (aspic viper). Toxicon 1990, 359-369.
68. Komori Y., Nikai T., Taniguchi K., Masuda K., Sugihara H. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (aspic viper). Biochemistry 1999, 38:11796-11803.
69. Krätzschmar J., Haendler B., Eberspaecher U., Roosterman D., Donner P., Schleuning W.D. The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur. J. Biochem. 1996, 15:827-836.
70. Krieger E.M., Salgado H.C., Assan C.J., Greene L.J., Ferreira S.H. Potential screening test for detection of overactivity of renin-angiotensin system. Lancet 1971, 269-271.
71. Lachmann P.J., Nicol P. Reaction mechanism of the alternative pathway of complement fixation. Lancet 1973, 1:465-467.
72. Landan G., Bdolah A., Wollberg Z., Kochva E., Graur D. The evolutionary history of the sarafotoxin/endothelin/endothelin-like superfamily. J. Cardiovasc. Pharmacol. 1991, 17:S517-S519.
73. LeCouter J., Ferrara N. EG-VEGF and Bv8: a novel family of tissue-selective mediators of angiogenesis, phenotype, endothelial and function. Trends Cardiovasc. Med. 2003, 13:276-282.
74. LeCouter J., Zlot C., Tejada M., Peale F., Ferrara N. Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. PNAS 2004, 101:16813-16818.
75. Leduc M., Bon C. Cloning of subunits of convulxin, a collagen-like platelet-aggregating protein from Crotalus durissus terrificus venom. Biochem. J. 1998, 333:389-393.
76. Lee S.Y., Lee C.Y., Chen Y.M., Kochva E. Coronary vasospasm as the primary cause of death due to the venom of the burrowing asp, Atractaspis engaddensis. Toxicon 1986, 24:285-291.
77. Lee C.Y., Chen H.H., Lisy O., Swan S., Cannon C., Lieu H.D., Burnett J.C. Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects. J. Clin. Pharmacol. 2009, 49:668-673.
78. Levi-Montalcini R., Meyer H., Hamburger V. In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res. 1954, 14:49-57.
79. Maillard J.L., Zarco R.M. Décomplémentation par un facteur entrail du venin de cobra. Effect sur plusieurs reactions immunes de cobaye et du rat. Ann. Inst. Pasteur. 1968, 114:756-774.
80. Marsh N., Williams V. Practical applications of snake venom toxins in haemostasis. Toxicon 2005, 45:1171-1181.
81. Martorana P.A., Linz W., Scholkens B.A. Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors?. Basic Res. Cardiol. 1991, 86:293-296.
82. Matsunaga Y., Yamazaki Y., Suzuki H., Morita T. VEGF-A and VEGF-F evoke distinct changes in vascular ultrastrucure. Biochem. Biophys. Res. Commun. 2009, 379:872-875.
83. Michalakis S., Kleppisch T., Polta S.A., Wotjak C.T., Koch S., Rammes G., Matt L., Becirovic E., Biel M. Altered synaptic plasticity and behavioral abnormalities in CNGA3-deficient mice. Genes Brain Behav 7 Oct 2010, [Epub ahead of print]. 10.1111/j.1601-183X.2010.00646.x.
84. Mizuno H., Fujimoto Z., Koizumi M., Kano H., Atoda H., Morita T. Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains. Nat. Struct. Biol. 1997, 4:438-441.
85. Mizuno H., Fujimoto Z., Atoda H., Morita T. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7230-7234.
86. Mochca-Morales J., Martin B.M., Possani L.D. Isolation and characterization of helothermine, a novel toxin from Heloderma horridum horridum (Mexican beaded lizard) venom. Toxicon 1990, 29:299-309.
87. Morita T. Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors. Int. J. Hematol. 2004, 79:123-129.
88. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 2005, 45:1099-1114.
89. Müller-Eberhard H.J., Fjellström K.E. Isolation of the anti-complementary protein from cobra venom and its mode of action on C3. J. Immunol. 1971, 107:1666-1672.
90. Müller-Eberhard H.J., Nilsson U.R., Dalmasso A.P., Polley M.A., Calcott M.A. A molecular concept of immune cytolysis. Arch. Pathol. 1966, 82:205-217.
91. Murakami M.T., Zela S.P., Gava L.M., Michelan-Duarte S., Cintra A.C., Arni R.K. Crystal structure of the platelet activator convulxin, a disulfide-linked α4β4 cyclic tetramer from the venom of Crotalus durissus terrificus. Biochem. Biophys. Res. Commun. 2003, 310:478-482.
92. Negri L., Lattanzi R., Giannini E., Melchiorri P. Modulators of pain: Bv8 and prokinectins. Curr. Neuropharm. 2006, 4:207-215.
93. Olivera B.M., Rivier J., Scott J.K., Hillyard D.R., Cruz L.J. Conotoxins. J. Biol. Chem. 1991, 266:22067-22070.
94. OmPraba G., Chapeaurouge A., Doley R., Devi K.R., Padmanaban P., Venkatraman C., Velmurugan D., Lin Q., Kini R.M. Identification of a novel family of snake venom proteins veficolins from Cerberus rynchops using a venom gland transcriptomics and proteomics approach. J. Proteome Res. 2010, 9:1882-1893.
95. Ondetti M.A., Williams N.J., Sabo E.F., Pluscec J., Weaver E.R., Kocy O. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 1971, 10:4033-4039.
96. Ouyang C., Teng C.M. Purification and properties of the anticoagulant principle of Agkistrodon acutus venom. Biochim. Biophys. Acta 1972, 278:155-162.
97. Ouyang C., Yang F.Y. Purification and properties of the thrombin-like enzyme from Trimeresurus gramineus venom. Biochim. Biophys. Acta 1974, 351:354-363.
98. Polgar J., Clemetson J.M., Kehrel B.E., Wiedemann M., Magnenat E.M., Wells T.N.C., Clemetson K.J. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J. Biol. Chem. 1997, 272:13576-13583.
99. Prado-Franceschi J., Brazil O.V. Convulxin, a new toxin from the venom of the South American rattlesnake Crotalus durissus terrificus. Toxicon 1981, 19:875-887.
100. Pung Y.F., Kumar S.V., Rajagopalan N., Fry B.G., Kumar P.P., Kini R.M. Ohanin, a novel protein from king cobra venom: its cDNA and genomic organization. Gene 2006, 371:246-256.
101. Read M.S., Shermer R.W., Brinkhous K.M. Venom coagglutinin - activator of platelet-aggregation dependent on von Willebrand factor. Proc. Nat. Acad. Sci. U. S. A. 1978, 75:4514-4518.
102. Roberts K.P., Johnston D.S., Nolan M.A., Wooters J.L., Waxmonsky N.C., Piehl L.B., Ensrud-Bowlin K.M., Hamilton D.W. Structure and function of epididymal protein cysteine-rich secretory protein-1. Asian J. Androl. 2007, 9:508-514.
103. Robertson B., Owen D., Stow J., Butler C., Newland C. Novel effects of dendrotoxin homologues on subtypes of mammalian Kv1 potassium channels expressed in Xenopus oocytes. FEBS Lett. 1996, 383:26-30.
104. Rocha e Silva M., Beraldo W.T., Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am. J. Physiol. 1949, 156:261-273.
105. Rosenthal T., Kissin E., Jacob E.T., Stern N., Levi Y., Adar R. Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension. Angiology 1979, 30:123-128.
106. Sano-Martins I.S., Tomy S.C., Campolina D., Dias M.B., de Castro S.C.B., de Sousa-e-Silva M.C.C., Amaral C.F.S., Rezende N.A., Kamiguti A.S., Warrell D.A., Theakston R.D.G. Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM 2001, 94:551-559.
107. Schweitz H., Vigne P., Moinier D., Frelin C., Lazdunski M. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J. Biol. Chem. 1992, 267:13928-13932.
108. Seegan G.W., Smith C.A., Schumaker V.N. Changes in quarternary structure of IgG upon reduction of the interheavy-chain disulfide bond. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:907-911.
109. 2+ ions. J. Biol. Chem. 1996, 271:8541-8544.
110. Serruto D., Rappuoli R., Scarselli M., Gros P., van Strijp J.A.G. Molecular mechanisms of complement evasion: learning from staphylococci and meningococci. Nat. Rev. Microbiol. 2010, 8:393-399.
111. 2+-bound Gla domain of factor IX complexed with binding protein. J. Biol. Chem. 2003, 278:24090-24094.
112. Skarzynski T. Crystal structure of alpha-dendrotoxin from the green mamba venom and its comparison with the structure of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 1992, 224:671-683.
113. Smith, C.A., 1979. Development and applications of new methods for high resolution transmission electron microscopy of biological macromolecules. Dissertation, University of California, Los Angeles.
114. Smith C.A., Vogel C.-W., Müller-Eberhard H.J. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement. J. Biol. Chem. 1982, 257:9879-9882.
115. Smith C.A., Vogel C.-W., Müller-Eberhard H.J. MHC class III products: an electron microscopic study of the C3 convertases of human complement. J. Exp. Med. 1984, 159:324-329.
116. Sokolovsky M., Galron R., Kloog Y., Bdolah A., Indig F.E., Blumburg S., Fleminger G. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4702-4706.
117. Strydom D.J., Botes D.P. Snake venom toxins. I. Preliminary studies on the separation of toxins of Elapidae venoms. Toxicon 1970, 8:203-209.
118. Sudoh T., Minamino N., Kanagawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 1990, 168:863-870.
119. Suhr B.D., Black S.M., Guzman-Paz M., Matas A.J., Dalmasso A.P. Inhibition of the membrane attack complex of complement for induction of accommodation in the hamster-to-rat heart transplant model. Xenotransplantation 2007, 14:572-579.
120. Suto K., Yamazaki Y., Morita T., Mizuno H. Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J. Biol. Chem. 2005, 280:2126-2131.
121. Suzuki N., Yamazaki Y., Brown R.L., Fujimoto Z., Morita T., Mizuno H. Structures of pseudechetoxin and pseudecin, two snake-venom cysteine-rich secretory proteins that target cyclic nucleotide-gated ion channels: implications for movement of the C-terminal cysteine-rich domain. Acta Crystallogr. D Biol. Crystallogr. 2008, 64:1034-1042.
122. Takasaki C., Tamiya N., Bdolah A., Wollberg Z., Kochva E. Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (Burrowing Asp) venom that affect the heart. Toxicon 1988, 26:543-548.
123. Teng C.M., Seegers W.H. Agkistrodon acutus snake venom inhibits prothrombinase complex formation. Thromb. Res. 1981, 23:255-263.
124. Togashi K., von Schimmelmann M.J., Nishiyama M., Lim C.S., Yoshida N., Yun B., Molday R.S., Goshima Y., Hong K. Cyclic GMP-gated CNG channels function in Sema3A-induced growth cone repulsion. Neuron 2008, 12:694-707.
125. Tokunaga Y., Yamazaki Y., Morita T. Specific distribution of VEGF-F in Viperinae snake venoms: isolation and characterization of a VEGF-F from the venom of Daboia russelli siamensis. Arch. Biochem. Biophys. 2005, 439:241-247.
126. Tokunaga Y., Yamazaki Y., Morita T. Localization of heparin- and neuropilin-1-recognition sites of viral VEGFs. Biochem. Biophys. Res. Commun. 2006, 348:957-962.
127. Utkin Y.N. Three-finger toxins, a deadly weapon of elapid venom - milestones of discovery. Toxicon 2013, 62:50-55.
128. van Gent D., Sharp P., Morgan K., Kalsheker N. Serpins: structure, function and molecular evolution. Int. J. Biochem. Cell. Bio. 2003, 35:1536-1547.
129. Vellard J., Huidobro F. Accion comparada de diversos venenos de ofidios sobre la pression arterial. Revta. Soc. Argent. Biol. 1941, 17:72+.
130. Vijayaraghavan J., Scicli A.G., Carretero O.A., Slaughter C., Moomaw C., Hersh L.B. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J. Biol. Chem. 1990, 265:14150-14155.
131. Viljoen C.C., Botes D.P. Snake venom toxins. The purification and amino acid sequence of toxin Ta2 from Dendroaspis angusticeps venom. J. Biol. Chem. 1974, 249:366-372.
132. Vogel C.-W., Fritzinger D.C. Cobra venom factor: structure, function, and humanization for therapeutic complement depletion. Toxicon 2010, 56:1198-1222.
133. Vogel C.-W., Müller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement: a kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 1982, 257:8292-8299.
134. Vogel C.-W., Müller-Eberhard H.J. Cobra venom factor: improved method for purification and biochemical characterization. J. Immunol. Meth. 1984, 73:203-220.
135. Vogel C.-W., Smith C.A., Müller-Eberhard H.J. Cobra venom factor: structural homology with the third component of human complement. J. Immunol. 1984, 133:3235-3241.
136. Vogt W., Schmidt G. Abtrennung des anaphylatoxinbildenden Prinzips aus Cobragift von anderen Giftkomponenten. Experientia 1964, 20:207-208.
137. Vogt W., Dieminger L., Lynen R., Schmidt G. Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe-Seyler's Z. Physiol. Chem. 1974, 355:171-183.
138. Ca channel. Biochemistry 2005, 44:10145-10152.
139. 2+- and heparin sulfate-dependent transcriptional regulation of endothelial cell adhesion molecules. J. Biol. Chem. 2010, 285:37872-37883.
140. Weiser E., Wollberg Z., Kochva E., Lee S.Y. Cardiotoxic effects of the venom of the burrowing asp, Atractaspis engaddensis (Atractaspididae, Ophidia). Toxicon 1984, 22:767-774.
141. Weller U., Bernhardt U., Siemen D., Dreyer F., Vogel W., Habermann E. Electrophysiological and neurobiochemical evidence for the blockade of a potassium channel by dendrotoxin. Naunyn Schmiedeberg's Arch. Pharmacol. 1985, 330:77-83.
142. Wollberg Z., Shabo-Shina R., Intrator N., Bdolah A., Kochva E., Shavit G., Oron Y., Vidne B.A., Gitter S. A novel cardiotoxic polypeptide from the venom of Atractaspis engaddensis (Burrowing Asp): cardiac effects in mice and isolated rat and human heart preparations. Toxicon 1988, 26:525-534.
143. Wong C.-O., Yao X. Cyclic nucleotide-gated channels: a familiar channel family with a new function?. Future Cardiol. 2008, 4:505-515.
144. 2+-dependent prothrombin activator. Thromb. Res. 1999, 94:221-226.
145. Yamada D., Sekiya F., Morita T. Isolation and characterization of carinactivase, novel prothrombin activator in Echis carinatus with a unique catalytic mechanism. J. Biol. Chem. 1996, 271:5200-5207.
146. Yamazaki Y., Morita T. Structure and function of snake venom cysteine-rich secretory proteins. Toxicon 2004, 44:227-231.
147. Yamazaki Y., Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol. Divers. 2006, 10:515-527.
148. Yamazaki Y., Morita T. Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Curr. Pharm. Des. 2007, 13:2872-2886.
149. Yamazaki Y., Brown R.L., Morita T. Purification and cloning of toxins from elapid venoms that target cyclic nucleotide-gated ion channels. Biochemistry 2002, 41:11331-11337.
150. Yamazaki Y., Koike H., Sugiyama Y., Motoyoshi K., Wada T., Hishinuma S., Mita M., Morita T. Cloning and characterization of novel snake venom proteins that block smooth muscle contraction. Eur. J. Biochem. 2002, 269:2708-2715.
151. Yamazaki Y., Takani K., Atoda H., Morita T. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J. Biol. Chem. 2003, 278:51985-51988.
152. Yamazaki Y., Matsunaga Y., Nakano Y., Morita T. Identification of vascular endothelial growth factor receptor-binding protein in the venom of eastern cottonmouth. J. Biol. Chem. 2005, 280:29989-29992.
153. Yamazaki Y., Tokunaga Y., Takani K., Morita T. C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation. Pathophys. Haemo. Thromb. 2005, 34:197-199.
154. Yamazaki Y., Tokunaga Y., Takani K., Morita T. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165. Biochemistry 2005, 44:8858-8864.
155. Yamazaki Y., Matsunaga Y., Tokunaga Y., Obayashi S., Saito M., Morita T. Snake venom vascular endothelial growth factors (VEGF-Fs) exclusively vary their structures and functions among species. J. Biol. Chem. 2010, 284:9885-9891.
156. Yanagisawa M., Kurihara H., Kimura S., Tomobo Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
157. Yang H.Y., Erdös E.G., Levin Y. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme). J. Pharmacol. Exp. Ther. 1971, 177:291-300.
158. Župunski V., KordiŠ D., GubenŠek F. Adaptive evolution in the snake venom Kunitz/BPTI protein family. FEBS Lett. 2003, 547:131-136.